Clinical and Safety Evaluation of Continuously Infused Ceftolozane/Tazobactam in the Outpatient Setting

Abstract

Ceftolozane/tazobactam delivered as a continuous infusion may be a safe, effective, and convenient way to treat infections caused by <i>P aeruginosa</i>. This novel treatment regimen can be an option for patients to avoid hospital admission or discharge to complete therapy as an outpatient.